Reem Al Sudairy
Reem Al Sudairy publishes mostly in Hematology, Oncology and Public Health, Environmental and Occupational Health, on topics such as Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research and Complementary and Alternative Medicine Studies.
- World rank
- #5,342,502 of 7,710,434 ranked researchers
- Rank in Saudi Arabia
- #20,688 of 25,688
- Works
- 19
- Citations
- 271
- Citations per work
- 14.3
What does Reem Al Sudairy research?
Reem Al Sudairy's work is mostly in Medicine (65%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1265.4%
- Medicine1265.4%
- Everything else629.1%
- Life Sciences15.5%
- 1Hematology16% of their works
- 2Oncology14% of their works
- 3Public Health, Environmental and Occupational Health14% of their works
- 4Complementary and alternative medicine13% of their works
- 5Pediatrics, Perinatology and Child Health7% of their works
- 6Molecular Biology6% of their works
Research topics
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Complementary and Alternative Medicine Studies
- Neutropenia and Cancer Infections
- Retinoids in leukemia and cellular processes
- Hematopoietic Stem Cell Transplantation
- Childhood Cancer Survivors' Quality of Life
- Phytochemistry Medicinal Plant Applications
Which keywords describe Reem Al Sudairy's research?
The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, AML, Childhood Cancer, Complementary Medicine and Herbal Medicine.
- Medicinal Plants
- Retinoic Acid
- Graft-versus-Host Disease
- Bone Marrow Niche
- Febrile Neutropenia
- Herbal Medicine
- Childhood Cancer
- Acute Lymphoblastic Leukemia
- Hematopoietic Stem Cells
- Prognostic Factors
- AML
- Acute Myeloid Leukemia
- Complementary Medicine
- Antimicrobial Agents
- Acute Promyelocytic Leukemia
- Childhood Cancer Survivor Study
- Pediatric Quality of Life Inventory
- Ethnobotany
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Prognostic Factors142 topics
- Hematopoietic Stem Cells92 topics
- AML71 topic
- Acute Lymphoblastic Leukemia71 topic
- Acute Myeloid Leukemia71 topic
- Childhood Cancer71 topic
- Complementary Medicine41 topic
- Herbal Medicine41 topic
- Antimicrobial Agents31 topic
- Febrile Neutropenia31 topic
- Acute Promyelocytic Leukemia21 topic
- Bone Marrow Niche21 topic
- Childhood Cancer Survivor Study21 topic
- Graft-versus-Host Disease21 topic
- Pediatric Quality of Life Inventory21 topic
- Retinoic Acid21 topic
- Ethnobotany11 topic
- Medicinal Plants11 topic
Where does Reem Al Sudairy work?
Reem Al Sudairy's main affiliation in the publication record is King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia.
How many publications and citations does Reem Al Sudairy have?
OpenAlex counts 19 works and 271 citations for Reem Al Sudairy, an h-index of 7, ranking #5,342,502 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Reem Al Sudairy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.